# Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD

> **NCT04741516** · PHASE4 · UNKNOWN · sponsor: **JPM van Stralen Medicine Professional** · enrollment: 41 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Foquest

## Key facts

- **NCT ID:** NCT04741516
- **Lead sponsor:** JPM van Stralen Medicine Professional
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04741516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04741516, "Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04741516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*